Dr. Wade Iams

Dr. Wade T. Iams, M.D., M.S.C.I., is a board-certified medical oncologist and Director of Lung Cancer Research at Tennessee Oncology, where he focuses on improving outcomes for patients with lung cancer. He earned his medical degree from the University of Michigan, completed his internal medicine residency at Vanderbilt University Medical Center, and pursued fellowship training in medical oncology at Northwestern University. He also holds a Master of Science in Clinical Investigation. Dr. Iams specializes in immunotherapy, targeted treatments, and precision medicine, with research centered on biomarker development and advancing personalized treatment strategies. He has authored numerous peer-reviewed publications and presents nationally on innovations in lung cancer care.

Dr. Iams is committed to translating emerging research into practical, patient-centered treatment plans. He is actively involved in clinical trials and works closely with multidisciplinary teams to integrate genetic testing and novel therapies into routine practice. Through research leadership and physician education, he aims to bridge cutting-edge science with real-world oncology care, helping both patients and fellow physicians navigate an increasingly complex treatment landscape.